Georgia Chenevix-Trench - JoVE Visualize

Showing results (21-30 of 415) with videos related to

Pageof 42

Sort By:

Gynecologic Oncology|October 16, 2007

The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia)Sharon E Johnatty, Christina M Nagle, Amanda B Spurdle, et al.

Genes, Chromosomes & Cancer|May 13, 2004

Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8James M Flanagan, Sue Healey, Joanne Young, et al.

Human Pathology|November 26, 2010

Application of molecular findings to the diagnosis and management of breast disease: recent advances and challengesPeter T Simpson, Ana-Cristina Vargas, Fares Al-Ejeh, et al.

Breast Cancer Research : BCR|May 1, 2007

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)Georgia Chenevix-Trench, Roger L Milne, Antonis C Antoniou, et al.

Breast Cancer Research and Treatment|June 27, 2007

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studiesSharon E Johnatty, Amanda B Spurdle, Jonathan Beesley, et al.

Breast Cancer Research : BCR|November 11, 2005

Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphismsChristopher Pettigrew, Nicola Wayte, Paul K Lovelock, et al.

Genes, Chromosomes & Cancer|January 21, 2004

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor APatricia A Mote, Jennifer A Leary, Kelly A Avery, et al.

BMJ Open|August 6, 2024

Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trialSimone McInerny, Lyon Mascarenhas, Tatiane Yanes, et al.

Lancet (London, England)|October 2, 2002

Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian womenAmanda B Spurdle, John L Hopper, Xiaoqing Chen, et al.

Nucleic Acids Research|May 6, 2014

A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapyChao Liu, Sriganesh Srihari, Kim-Anh Lê Cao, et al.

Pageof 42

Showing results (21-30 of 415) with videos related to

Sort By:

Pageof 42

Gynecologic Oncology|October 16, 2007

The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia)Sharon E Johnatty, Christina M Nagle, Amanda B Spurdle, et al.

Genes, Chromosomes & Cancer|May 13, 2004

Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8James M Flanagan, Sue Healey, Joanne Young, et al.

Human Pathology|November 26, 2010

Application of molecular findings to the diagnosis and management of breast disease: recent advances and challengesPeter T Simpson, Ana-Cristina Vargas, Fares Al-Ejeh, et al.

Breast Cancer Research : BCR|May 1, 2007

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)Georgia Chenevix-Trench, Roger L Milne, Antonis C Antoniou, et al.

Breast Cancer Research and Treatment|June 27, 2007

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studiesSharon E Johnatty, Amanda B Spurdle, Jonathan Beesley, et al.

Breast Cancer Research : BCR|November 11, 2005

Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphismsChristopher Pettigrew, Nicola Wayte, Paul K Lovelock, et al.

Genes, Chromosomes & Cancer|January 21, 2004

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor APatricia A Mote, Jennifer A Leary, Kelly A Avery, et al.

BMJ Open|August 6, 2024

Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trialSimone McInerny, Lyon Mascarenhas, Tatiane Yanes, et al.

Lancet (London, England)|October 2, 2002

Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian womenAmanda B Spurdle, John L Hopper, Xiaoqing Chen, et al.

Nucleic Acids Research|May 6, 2014

A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapyChao Liu, Sriganesh Srihari, Kim-Anh Lê Cao, et al.

Pageof 42